Patient advocacy groups play an increasingly important role in the drug development and regulatory process. Biopharmaceutical companies that truly want to be patient-centered should engage these groups early, often, and enthusiastically.
Patient advocates are becoming savvier navigators, instigators, and research engines, and in the process making themselves indispensable partners for the biopharmaceutical industry. The question is not whether to engage with patient advocacy, it’s how.
Download this paper to learn how engaging with Patient Advocacy Groups can help:
- Support and guide R&D
- Inform and refine patient support services
- Identify and educate patients
- Influence regulation and policy
Comments are closed